Response to anti-DKK1 therapy in uterine carcinosarcoma: A case report

Targeted therapies are being increasingly used in clinical practice and trials. However, tumor heterogeneity among sites of metastatic disease can occur creating a conundrum when utilizing biomarker directed therapies. Here we demonstrate a patient with recurrent uterine carcinosarcoma whose local r...

Descripción completa

Detalles Bibliográficos
Autores principales: ElNaggar, A., Zhang, N., Scalise, C.B., Sirard, C., Kagey, M.H., Vaena, D., Arend, R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9068954/
https://www.ncbi.nlm.nih.gov/pubmed/35531363
http://dx.doi.org/10.1016/j.gore.2021.100904

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9068954/
https://www.ncbi.nlm.nih.gov/pubmed/35531363
http://dx.doi.org/10.1016/j.gore.2021.100904

Ejemplares similares